We generated numerous Nectin-2-specific fully human monoclonal antibodies (mAbs) and demonstrated the anti-tumor effect of the selected mAb clone, Y-443 (human IgG1/kappa), on breast cancer and ovarian cancer cells [21]. This evidence concerns the gene NECTIN2 and neoplasm.